GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

Higher levels of GP73 can be found in the serum of patients with HCC than of those without. GP73 was better than AFP for the diagnosis of early HCC. Further validation studies are needed to confirm the role of GP73 in the early detection of HCC.